Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren vs Irbesartan in Diabetic Nephropathy
NCT00464880Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aliskiren in diabetic nephropathy (DN), sponsored by Novartis. Started Sep 2005; status: completed.
02
Drugs
aliskiren
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00464880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00464880.